Genmab A (GMAB) Receivables - Other: 2019-2020
- Genmab A's Receivables - Other rose 95.49% to $11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $11.4 million, marking a year-over-year increase of 95.49%. This contributed to the annual value of $11.4 million for FY2020, which is 95.49% up from last year.
- As of Q4 2020, Genmab A's Receivables - Other stood at $11.4 million, which was up 95.49% from $5.8 million recorded in Q4 2019.
- In the past 5 years, Genmab A's Receivables - Other ranged from a high of $11.4 million in Q4 2020 and a low of $5.8 million during Q4 2019.
- Moreover, its 2-year median value for Receivables - Other was $8.6 million (2020), whereas its average is $8.6 million.
- Data for Genmab A's Receivables - Other shows a peak YoY skyrocketed of 95.49% (in 2020) over the last 5 years.
- Over the past 2 years, Genmab A's Receivables - Other (Quarterly) stood at $5.8 million in 2019, then skyrocketed by 95.49% to $11.4 million in 2020.
